These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23636430)

  • 21. Cerebral metabolic alterations and cognitive dysfunction in children with chronic kidney disease using magnetic resonance spectroscopy and Wechsler intelligence scale.
    Youssef DM; Mohamed AH; Attia WMK; Mohammad FF; El Fatah NRA; El-Shal AS
    Nephrology (Carlton); 2018 Aug; 23(8):771-777. PubMed ID: 28621826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA damage in hemodialysis patients with chronic kidney disease; a test of the role of diabetes mellitus; a comet assay investigation.
    Mamur S; Unal F; Altok K; Deger SM; Yuzbasioglu D
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Apr; 800-801():22-7. PubMed ID: 27085471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abdominal aorta and pelvic artery calcifications on plain radiographs may predict mortality in chronic kidney disease, hemodialysis and renal transplantation.
    Disthabanchong S; Vipattawat K; Phakdeekitcharoen B; Kitiyakara C; Sumethkul V
    Int Urol Nephrol; 2018 Feb; 50(2):355-364. PubMed ID: 29236239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors of Parathyroid Dysfunction in Elderly Patients with Chronic Kidney Disease Undergoing Hemodialysis.
    Li W; Zhang S
    Adv Clin Exp Med; 2015; 24(6):1007-12. PubMed ID: 26771973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of CKD and dialysis modality on exposure to drugs cleared by nonrenal mechanisms.
    Thomson BK; Nolin TD; Velenosi TJ; Feere DA; Knauer MJ; Asher LJ; House AA; Urquhart BL
    Am J Kidney Dis; 2015 Apr; 65(4):574-82. PubMed ID: 25453994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive Testing in Patients with CKD: The Problem of Missing Cases.
    Neumann D; Robinski M; Mau W; Girndt M
    Clin J Am Soc Nephrol; 2017 Mar; 12(3):391-398. PubMed ID: 28148556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic guidelines fulfillment in clinical practice in patients with chronic kidney disease (CKD)].
    Verdalles U; García de Vinuesa S; Goicoechea M; Gómez Campderá F; Luño J
    Nefrologia; 2007; 27(3):320-8. PubMed ID: 17725451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
    Griffith TF; Chua BS; Allen AS; Klassen PS; Reddan DN; Szczech LA
    Am J Kidney Dis; 2003 Dec; 42(6):1260-9. PubMed ID: 14655199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ; Ceballos M;
    Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive Dysfunction in Patients with Chronic Kidney Disease.
    Aggarwal HK; Jain D; Bhavikatti A
    Saudi J Kidney Dis Transpl; 2020; 31(4):796-804. PubMed ID: 32801240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of Residual Renal Function in Carotid Modeling as a Marker of Early Atherosclerosis in Dialysis Patients.
    Rroji M; Spahia N; Seferi S; Barbullushi M; Spasovski G
    Ther Apher Dial; 2017 Oct; 21(5):451-458. PubMed ID: 28714271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of sleep-disordered breathing with cognitive dysfunction in CKD stages 4-5.
    Kang EW; Abdel-Kader K; Yabes J; Glover K; Unruh M
    Am J Kidney Dis; 2012 Dec; 60(6):949-58. PubMed ID: 23063144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive factors associated with increased progression to dialysis in early chronic kidney disease (stage 1-3) patients.
    Nohara N; Io H; Matsumoto M; Furukawa M; Okumura K; Nakata J; Shimizu Y; Horikoshi S; Tomino Y
    Clin Exp Nephrol; 2016 Oct; 20(5):740-747. PubMed ID: 26707759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of homocysteine level and vascular burden and cognitive function in middle-aged and older adults with chronic kidney disease.
    Yeh YC; Huang MF; Hwang SJ; Tsai JC; Liu TL; Hsiao SM; Yang YH; Kuo MC; Chen CS
    Int J Geriatr Psychiatry; 2016 Jul; 31(7):723-30. PubMed ID: 26553116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-dependent parathormone levels and different CKD-MBD treatment practices of dialysis patients in Hungary--results from a nationwide clinical audit.
    Kiss I; Kiss Z; Ambrus C; Szabó A; Szegedi J; Balla J; Ladányi E; Csiky B; Árkossy O; Török M; Túri S; Kulcsár I;
    BMC Nephrol; 2013 Jul; 14():155. PubMed ID: 23865464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
    J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary hyperparathyroidism is associated with pulmonary hypertension in older patients with chronic kidney disease and proteinuria.
    Genctoy G; Arikan S; Gedik O
    Int Urol Nephrol; 2015 Feb; 47(2):353-8. PubMed ID: 25537827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of executive function after dialysis initiation in adults with chronic kidney disease.
    Kurella Tamura M; Vittinghoff E; Hsu CY; Tam K; Seliger SL; Sozio S; Fischer M; Chen J; Lustigova E; Strauss L; Deo R; Go AS; Yaffe K;
    Kidney Int; 2017 Apr; 91(4):948-953. PubMed ID: 28139292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial).
    Imai E; Maruyama S; Nangaku M; Hirakata H; Hayashi T; Narita I; Kono H; Nakatani E; Morita S; Tsubakihara Y; Akizawa T
    Clin Exp Nephrol; 2016 Feb; 20(1):71-6. PubMed ID: 26081567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.